---

---

entities : Myriad genetics, inc.    symbols : LH   

save search

---

Global and Regional Next-Generation IVD Market Report 2023: Market Value to Surpass $150 Billion by 2033 - Rising Demand of POC Testing Boosting Growth Prospects
Published: 2023-10-20 (Crawled : 10:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M |

Health Technology

| 16.19% | O: -0.35% H: 0.0% C: 0.0%
DGX | $125.91 -0.84% -0.7% 870K |

Health Services

| 3.74% | O: 0.68% H: 1.33% C: 0.05%
QGEN | $39.47 0.61% 0.0% 950K |

Health Technology

| 4.45% | O: 0.16% H: 0.88% C: -0.13%
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| 0.27% | O: 0.49% H: 0.43% C: -0.27%
DHR | $236.36 -1.27% 0.0% 4.2M |

Health Technology

| 15.94% | O: -0.0% H: 0.92% C: -0.7%
BIO | $281.02 -3.38% -0.36% 370K |

Health Technology

| -7.35% | O: -0.15% H: 0.74% C: -1.5%
BDX | $233.15 0.41% 0.15% 890K |

Health Technology

| -10.28% | O: 0.03% H: 1.58% C: 0.42%
A | $132.44 -1.57% -0.36% 1.9M |

Health Technology

| 25.21% | O: 0.26% H: 0.96% C: -0.28%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| 12.58% | O: -0.45% H: 0.0% C: 0.0%
QGEN | $39.47 0.61% 0.0% 950K |

Health Technology

| 4.45% | O: 0.16% H: 0.88% C: -0.13%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| 27.15% | O: 0.41% H: 3.13% C: 2.38%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -1.41% | O: 0.02% H: 0.94% C: -0.3%
report global poc growth market

---

Multicancer Screening Global Market Report 2023: Sector to Reach $7.78 Billion by 2032 at a 15% CAGR
Published: 2023-05-29 (Crawled : 19:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M |

Health Technology

| 4.83% | O: 0.34% H: 0.5% C: -1.83%
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -7.25% | O: -0.35% H: 0.43% C: -1.35%
NVTA | $0.019 0.0% 22M |

Health Services

| -98.21% | O: 1.89% H: 3.7% C: -2.78%
DHR | $236.36 -1.27% 0.0% 4.2M |

Health Technology

| 3.5% | O: 0.34% H: 0.58% C: -2.49%
A | $132.44 -1.57% -0.36% 1.9M |

Health Technology

| 13.6% | O: -0.34% H: 1.08% C: -1.9%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -16.38% | O: 0.18% H: 3.02% C: -0.31%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -39.61% | O: 0.15% H: 1.16% C: -0.86%
GH M | $16.68 1.77% 1.74% 1.6M |

Health Services

| -41.63% | O: 2.24% H: 3.41% C: -0.17%
EXAS | $63.45 0.36% 0.36% 1.6M |

Health Technology

| -22.13% | O: 0.67% H: 2.45% C: -1.72%
ATRA | $0.6917 -3.25% -3.35% 830K |

Health Technology

| -61.49% | O: -0.56% H: 6.25% C: -7.95%
report reach global market

---

Global Multicancer Screening Market to Reach $7.78 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS Research
Published: 2023-04-28 (Crawled : 15:20) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M |

Health Technology

| 0.78% | O: 0.06% H: 2.92% C: 2.13%
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -11.0% | O: -0.41% H: 1.77% C: 1.31%
NVTA | $0.019 0.0% 22M |

Health Services

| -98.6% | O: -0.74% H: 3.7% C: 0.74%
DHR | $236.36 -1.27% 0.0% 4.2M |

Health Technology

| 3.85% | O: 0.48% H: 3.03% C: 1.88%
A | $132.44 -1.57% -0.36% 1.9M |

Health Technology

| 2.66% | O: 0.15% H: 2.61% C: 1.48%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -12.03% | O: -0.14% H: 2.65% C: 0.61%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -42.13% | O: -0.36% H: 2.89% C: 0.93%
GH M | $16.68 1.77% 1.74% 1.6M |

Health Services

| -24.4% | O: 0.0% H: 5.54% C: 4.06%
EXAS | $63.45 0.36% 0.36% 1.6M |

Health Technology

| 0.66% | O: -1.09% H: 3.16% C: 2.1%
ATRA | $0.6917 -3.25% -3.35% 830K |

Health Technology

| -73.58% | O: -0.39% H: 9.92% C: 5.45%
reach research global market

---

Genetic Testing Market to Reach $28.24 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®
Published: 2023-03-20 (Crawled : 15:20) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M |

Health Technology

| -0.02% | O: -0.11% H: 1.48% C: 0.7%
PKI | $115.24 0.0% 1.6M |

Health Technology

| -7.36% | O: -2.64% H: 2.21% C: 1.27%
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -6.26% | O: 0.35% H: 1.63% C: 1.55%
NTRA | $87.19 -3.48% -3.6% 1.1M |

Health Services

| 59.51% | O: -0.23% H: 1.0% C: -0.42%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -19.24% | O: 0.74% H: 2.75% C: 2.15%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -47.32% | O: -0.4% H: 0.07% C: -1.73%
FLGT | $20.12 0.15% 0.15% 220K |

Health Services

| -34.86% | O: 0.81% H: 2.64% C: -0.23%
CNTG | $0.461 -3.96% -4.12% 23K |

Commercial Services

| -45.44% | O: 5.53% H: 0.0% C: -9.28%
research report genetic trends market

---

United States Women Health Laboratory Testing Markets Report 2022-2030 Featuring Ascension, EKF, Gateway Genomics, Laboratory Corp of America, Myriad Genetics, Natera, Ovia Health, Roche, & Yourgene
Published: 2023-02-20 (Crawled : 12:00) - prnewswire.com
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| Email alert Add to watchlist
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| Email alert Add to watchlist
NTRA | $87.19 -3.48% -3.6% 1.1M |

Health Services

| Email alert Add to watchlist
report women health

---

Pancreatic Cancer Diagnostics Market is Likely to Upsurge at a CAGR of 7.5% by 2030, Size, Share, Trends, Demand, Growth, Opportunities and Competitors Analysis
Published: 2023-01-24 (Crawled : 21:00) - prnewswire.com
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -21.27% | O: -0.58% H: 0.85% C: 0.47%
PHG | News | $19.98 -0.84% 0.0% 500K |

Health Technology

| 24.48% | O: -0.89% H: 0.75% C: 0.12%
A | $132.44 -1.57% -0.36% 1.9M |

Health Technology

| -12.13% | O: -1.09% H: 1.65% C: 1.14%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -11.11% | O: -1.0% H: 0.1% C: -1.2%
diagnostics cancer market pancreatic

---

United States Hereditary Genetic Testing Markets,2022-2032: Technological Advancements for Exome Sequencing/Rise of Direct-to-Consumer (DTC) Testing Services Leading to Multi-Billion Opportunities
Published: 2023-01-11 (Crawled : 12:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M |

Health Technology

| -3.66% | O: 0.54% H: 2.41% C: 2.0%
DGX | $125.91 -0.84% -0.7% 870K |

Health Services

| -16.47% | O: 0.24% H: 0.6% C: -0.04%
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -18.48% | O: 0.96% H: 2.74% C: 2.65%
NVTA | $0.019 0.0% 22M |

Health Services

| -99.1% | O: 2.36% H: 9.68% C: 9.68%
A | $132.44 -1.57% -0.36% 1.9M |

Health Technology

| -11.87% | O: 0.0% H: 2.16% C: 1.89%
NTRA | $87.19 -3.48% -3.6% 1.1M |

Health Services

| 139.28% | O: 0.66% H: 9.53% C: 8.55%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| 7.62% | O: 0.0% H: 8.08% C: 6.7%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -39.17% | O: 1.36% H: 3.96% C: 3.53%
FLGT | $20.12 0.15% 0.15% 220K |

Health Services

| -33.85% | O: -0.03% H: 2.44% C: 2.11%
EXAS | $63.45 0.36% 0.36% 1.6M |

Health Technology

| 6.27% | O: 0.68% H: 11.09% C: 11.07%
CNTG | $0.461 -3.96% -4.12% 23K |

Commercial Services

| -50.0% | O: -0.02% H: 1.04% C: 1.04%
services genetic

---

U.S. hereditary genetic testing market was valued at $7.57 billion in 2021 and is expected to grow with a CAGR of 13.09% and reach $29.28 billion by 2032
Published: 2022-11-28 (Crawled : 15:00) - prnewswire.com
DGX | $125.91 -0.84% -0.7% 870K |

Health Services

| -14.52% | O: -0.13% H: 0.69% C: 0.14%
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -17.15% | O: -0.38% H: 0.3% C: -0.87%
NTRA | $87.19 -3.48% -3.6% 1.1M |

Health Services

| 140.37% | O: -0.82% H: 1.64% C: 0.64%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -5.09% | O: -1.63% H: 2.02% C: -2.43%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -45.98% | O: -0.76% H: 1.23% C: -0.19%
genetic expected market

---

Next-Generation Gynecological Cancer Diagnostics Market, 2031
Published: 2022-04-27 (Crawled : 10:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M |

Health Technology

| 2.05% | O: -2.87% H: 0.0% C: 0.0%
DGX | $125.91 -0.84% -0.7% 870K |

Health Services

| -6.07% | O: -0.43% H: 3.45% C: 1.79%
QGEN | $39.47 0.61% 0.0% 950K |

Health Technology

| -12.53% | O: 0.91% H: 1.37% C: 0.09%
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -23.18% | O: -3.91% H: 2.25% C: 1.17%
NVTA | $0.019 0.0% 22M |

Health Services

| -99.65% | O: -6.95% H: 4.32% C: -1.38%
A | $132.44 -1.57% -0.36% 1.9M |

Health Technology

| 13.19% | O: -2.2% H: 2.24% C: -0.44%
QGEN | $39.47 0.61% 0.0% 950K |

Health Technology

| -12.53% | O: 0.91% H: 1.37% C: 0.09%
OPK | $1.235 -1.2% -1.21% 4.1M |

Health Technology

| -58.47% | O: -6.64% H: 1.78% C: -1.42%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -14.34% | O: -2.62% H: 3.04% C: 0.09%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -62.15% | O: -3.78% H: 2.05% C: -1.05%
FLGT | $20.12 0.15% 0.15% 220K |

Health Services

| -64.71% | O: -3.5% H: 3.75% C: 0.29%
CNTG | $0.461 -3.96% -4.12% 23K |

Commercial Services

| -86.36% | O: -2.84% H: 1.46% C: -1.17%
diagnostics cancer diagnostic

---

Carrier Screening Markets, 2031 - Rising Emphasis on Early Detection and Prevention of Complex Genetic Disorders
Published: 2022-03-11 (Crawled : 17:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M |

Health Technology

| 1.87% | O: 0.89% H: 0.0% C: 0.0%
DGX | $125.91 -0.84% -0.7% 870K |

Health Services

| -6.29% | O: 0.42% H: 0.0% C: 0.0%
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -24.89% | O: 0.21% H: 0.0% C: 0.0%
NVTA | $0.019 0.0% 22M |

Health Services

| -99.77% | O: -0.12% H: 0.0% C: 0.0%
NTRA | $87.19 -3.48% -3.6% 1.1M |

Health Services

| 114.2% | O: -0.26% H: 0.0% C: 0.0%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -31.62% | O: 0.95% H: 0.0% C: 0.0%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -62.57% | O: 1.34% H: 0.0% C: 0.0%
FLGT | $20.12 0.15% 0.15% 220K |

Health Services

| -64.05% | O: 1.41% H: 0.0% C: 0.0%
CNTG | $0.461 -3.96% -4.12% 23K |

Commercial Services

| -86.77% | O: -1.38% H: 0.0% C: 0.0%
genetic order

---

Labcorp Completes Acquisition of Myriad Autoimmune’s Vectra Testing Business
Published: 2021-09-13 (Crawled : 23:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -33.55% | O: 0.07% H: 0.2% C: -1.23%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -43.91% | O: -0.09% H: 0.0% C: -1.51%
acquisition test

---

Global Direct-to-Consumer Genetic Testing Market 2021: Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations - Forecast to 2031
Published: 2021-08-20 (Crawled : 19:00) - prnewswire.com
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| Email alert Add to watchlist
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| Email alert Add to watchlist
genetic test genomic

---

Worldwide Reproductive Genetics Industry to 2030 - Rising Funding and Innovations Presents Opportunities
Published: 2021-06-14 (Crawled : 19:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M |

Health Technology

| 16.42% | O: 0.57% H: 0.15% C: -0.56%
QGEN | $39.47 0.61% 0.0% 950K |

Health Technology

| -17.27% | O: 0.7% H: 0.19% C: -0.13%
PKI | $115.24 0.0% 1.6M |

Health Technology

| -20.97% | O: 1.22% H: 0.0% C: -0.56%
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -23.04% | O: 0.43% H: 0.44% C: -0.2%
NVTA | $0.019 0.0% 22M |

Health Services

| -99.94% | O: 0.35% H: 0.32% C: -3.57%
A | $132.44 -1.57% -0.36% 1.9M |

Health Technology

| -5.26% | O: 0.32% H: 0.21% C: -0.16%
QGEN | $39.47 0.61% 0.0% 950K |

Health Technology

| -17.27% | O: 0.7% H: 0.19% C: -0.13%
OPK | $1.235 -1.2% -1.21% 4.1M |

Health Technology

| -65.56% | O: 1.93% H: 0.81% C: -0.27%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -37.74% | O: -0.43% H: 1.38% C: 0.5%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -73.84% | O: 0.08% H: 0.32% C: -0.15%
FLGT | $20.12 0.15% 0.15% 220K |

Health Services

| -73.07% | O: -0.4% H: 0.22% C: -2.65%
funding genetic

---

Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
Published: 2021-05-03 (Crawled : 21:00) - globenewswire.com
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -25.2% | O: 0.5% H: 2.03% C: 1.83%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -38.68% | O: -0.39% H: 5.68% C: 4.43%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -69.39% | O: -0.58% H: 0.0% C: -1.5%
CSTL | $19.19 1.86% 1.82% 140K |

Health Technology

| -71.61% | O: -2.25% H: 0.43% C: -0.74%
genetic ev growth liver

---

Labcorp to Acquire Myriad Autoimmune’s Vectra Testing Business From Myriad Genetics
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -24.79% | O: 0.8% H: 0.71% C: -0.25%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -38.32% | O: 2.12% H: 0.0% C: -1.49%
genetic test

---

Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to Labcorp
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
LH M | $199.45 -0.26% 0.27% 770K |

Health Services

| -24.79% | O: 0.8% H: 0.71% C: -0.25%
MYGN | News F | $18.51 -0.7% -0.7% 640K |

Health Technology

| -38.32% | O: 2.12% H: 0.0% C: -1.49%
genetic test

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---